247 related articles for article (PubMed ID: 25362533)
1. On the transmethylation hypothesis: stress, N,N-dimethyltryptamine, and positive symptoms of psychosis.
Grammenos D; Barker SA
J Neural Transm (Vienna); 2015 Jun; 122(6):733-9. PubMed ID: 25362533
[TBL] [Abstract][Full Text] [Related]
2. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.
Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Obradovic M; Kovar KA
Pharmacopsychiatry; 2005 Nov; 38(6):301-11. PubMed ID: 16342002
[TBL] [Abstract][Full Text] [Related]
3. When the endogenous hallucinogenic trace amine N,N-dimethyltryptamine meets the sigma-1 receptor.
Su TP; Hayashi T; Vaupel DB
Sci Signal; 2009 Mar; 2(61):pe12. PubMed ID: 19278957
[TBL] [Abstract][Full Text] [Related]
4. N,N-Dimethyltryptamine-Induced Psychosis.
Paterson NE; Darby WC; Sandhu PS
Clin Neuropharmacol; 2015; 38(4):141-3. PubMed ID: 26166234
[TBL] [Abstract][Full Text] [Related]
5. Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis.
Heekeren K; Neukirch A; Daumann J; Stoll M; Obradovic M; Kovar KA; Geyer MA; Gouzoulis-Mayfrank E
J Psychopharmacol; 2007 May; 21(3):312-20. PubMed ID: 17591658
[TBL] [Abstract][Full Text] [Related]
6. Dimethyltryptamine (DMT): subjective effects and patterns of use among Australian recreational users.
Cakic V; Potkonyak J; Marshall A
Drug Alcohol Depend; 2010 Sep; 111(1-2):30-7. PubMed ID: 20570058
[TBL] [Abstract][Full Text] [Related]
7. Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamine.
Jacob MS; Presti DE
Med Hypotheses; 2005; 64(5):930-7. PubMed ID: 15780487
[TBL] [Abstract][Full Text] [Related]
8. Ayahoasca: an experimental psychosis that mirrors the transmethylation hypothesis of schizophrenia.
Pomilio AB; Vitale AA; Ciprian-Ollivier J; Cetkovich-Bakmas M; Gómez R; Vázquez G
J Ethnopharmacol; 1999 Apr; 65(1):29-51. PubMed ID: 10350367
[TBL] [Abstract][Full Text] [Related]
9. Dark Classics in Chemical Neuroscience: N, N-Dimethyltryptamine (DMT).
Cameron LP; Olson DE
ACS Chem Neurosci; 2018 Oct; 9(10):2344-2357. PubMed ID: 30036036
[TBL] [Abstract][Full Text] [Related]
10. A Physician's Attempt to Self-Medicate Bipolar Depression with N,N-Dimethyltryptamine (DMT).
Brown T; Shao W; Ayub S; Chong D; Cornelius C
J Psychoactive Drugs; 2017; 49(4):294-296. PubMed ID: 28686543
[TBL] [Abstract][Full Text] [Related]
11. The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator.
Fontanilla D; Johannessen M; Hajipour AR; Cozzi NV; Jackson MB; Ruoho AE
Science; 2009 Feb; 323(5916):934-7. PubMed ID: 19213917
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of return in the human 5HT2A agonist and NMDA antagonist model of psychosis.
Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Daumann J; Obradovic M; Kovar KA
Neuropsychopharmacology; 2006 Feb; 31(2):431-41. PubMed ID: 16123739
[TBL] [Abstract][Full Text] [Related]
13. [Effects of N,N-dimethyltryptamine (DMT) on tests of psychoticism (author's transl)].
Bickel P; Dittrich A; Schöpf J
Pharmakopsychiatr Neuropsychopharmakol; 1977 Jan; 10(1):10-4. PubMed ID: 329291
[TBL] [Abstract][Full Text] [Related]
14. Editorial: Dimethyltryptamine and psychosis.
Lancet; 1974 Jul; 2(7873):140-1. PubMed ID: 4135558
[No Abstract] [Full Text] [Related]
15. Increased excretion of dimethyltryptamine and certain features of psychosis: a possible association.
Murray RM; Oon MC; Rodnight R; Birley JL; Smith A
Arch Gen Psychiatry; 1979 Jun; 36(6):644-9. PubMed ID: 286576
[TBL] [Abstract][Full Text] [Related]
16. Chronic, Intermittent Microdoses of the Psychedelic
Cameron LP; Benson CJ; DeFelice BC; Fiehn O; Olson DE
ACS Chem Neurosci; 2019 Jul; 10(7):3261-3270. PubMed ID: 30829033
[TBL] [Abstract][Full Text] [Related]
17. Metabolism and urinary disposition of N,N-dimethyltryptamine after oral and smoked administration: a comparative study.
Riba J; McIlhenny EH; Bouso JC; Barker SA
Drug Test Anal; 2015 May; 7(5):401-6. PubMed ID: 25069786
[TBL] [Abstract][Full Text] [Related]
18. The psychedelic model of schizophrenia: the case of N,N-dimethyltryptamine.
Gillin JC; Kaplan J; Stillman R; Wyatt RJ
Am J Psychiatry; 1976 Feb; 133(2):203-8. PubMed ID: 1062171
[TBL] [Abstract][Full Text] [Related]
19. Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca.
Riba J; McIlhenny EH; Valle M; Bouso JC; Barker SA
Drug Test Anal; 2012; 4(7-8):610-6. PubMed ID: 22514127
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the brain levels of N,N-dimethyltryptamine and alpha, alpha, beta, beta-tetradeutero-N-N-dimethyltryptamine following intraperitoneal injection. The in vivo kinetic isotope effect.
Barker SA; Beaton JM; Christian ST; Monti JA; Morris PE
Biochem Pharmacol; 1982 Aug; 31(15):2513-6. PubMed ID: 6812592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
